About

Christian Roesky is chief executive officer of Novaliq GmbH. Dr Roesky holds a PhD in Chemistry, has been involved in eye care for more than 15 years and has extensive operational experience at multiple international pharmaceutical companies. Previously, Dr Roesky has served as general manager of Bausch + Lomb GmbH / Dr Mann GmbH in Berlin; managing director of the Diagnostics Division and general manager and speaker of the Country Management Board of Abbott GmbH & Co KG in Wiesbaden; and general manager of Alcon Germany & Austria (Novartis).

Contributions

OCULAR

BREAKING THE VICIOUS CIRCLE OF DRY EYE DISEASE

Christian Roesky discusses the underserved condition of dry eye disease, and presents two products in Novaliq’s pipelinefor the treatment of different types of DED.

More contributions

OCULAR

AQUEOUS-FREE OPHTHALMIC DELIVERY TECHNOLOGY

Traditional aqueous vehicles for topical ophthalmic medications suffer from a number of limitations. Christian Roesky reviews the benefits of EyeSol®, a proprietary aqueous-free drug delivery technology.